Investor Relations

Corporate Profile

PharmAthene was formed in 2001 to meet the critical needs of this Nation and its Allies by developing biological and chemical defense products. The Company is dedicated to the rapid development of important and novel biotherapeutics to address biological pathogens and chemicals that may be used... More >>

NYSE Amex - PIP (Common Stock)
$1.64 + 0.01
Stock chart for: PIP.A.  Currently trading at $1.64 with a 52 week high of $2.59 and a 52 week low of $1.19.
04/01/15 3:58 p.m. ET
Data Provided by Thomson Reuters

Recent News

PharmAthene Reports Year-End 2014 Financial And Operational Results; Announces Plan To Realign Operational Resources

Read More

PharmAthene rPA Antigen Formulated With DepoVax™ Demonstrates Promise As Single Unit Dose Anthrax Vaccine

Read More

PharmAthene Awarded $195 Million Plus Post-Judgment Interest By Delaware Court Of Chancery

Read More

Upcoming Event

There are currently no events scheduled.

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
*PharmAthene, Inc. makes no representations or warranties with respect to the accuracy or completeness of the information provided herein and assumes no responsibility for correcting, updating, or supplementing any such information.